These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36445386)

  • 1. Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
    Abella LMR; Hoffmann R; Neumann J; Hofmann B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):669-682. PubMed ID: 36445386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    Galindo-Tovar A; Kaumann AJ
    Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
    Orstavik O; Ata SH; Riise J; Dahl CP; Andersen GØ; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2014 Dec; 171(23):5169-81. PubMed ID: 24547784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H
    Neumann J; Voss R; Laufs U; Werner C; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1215-1229. PubMed ID: 33576869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
    Usta C; Puddu PE; Papalia U; De Santis V; Vitale D; Tritapepe L; Mazzesi G; Miraldi F; Ozdem SS
    J Cardiovasc Pharmacol; 2004 Nov; 44(5):622-5. PubMed ID: 15505502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
    Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
    J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
    Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature alters the inotropic, chronotropic and proarrhythmic effects of histamine in atrial muscle preparations from humans and H
    Hoffmann RJR; Gergs U; Hofmann B; Kirchhefer U; Neumann J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2137-2150. PubMed ID: 36951998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of bufotenin on human 5-HT
    Neumann J; Schulz N; Fehse C; Azatsian K; Čináková A; Marušáková M; Hofmann B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1471-1485. PubMed ID: 36754881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
    Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cantharidin increases the force of contraction and protein phosphorylation in isolated human atria.
    Schwarz R; Hofmann B; Gergs U; Neumann J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2613-2625. PubMed ID: 37097333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations.
    Neumann J; Azatsian K; Höhm C; Hofmann B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):275-287. PubMed ID: 36319858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
    Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
    Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium.
    Ørstavik Ø; Manfra O; Andressen KW; Andersen GØ; Skomedal T; Osnes JB; Levy FO; Krobert KA
    PLoS One; 2015; 10(3):e0115547. PubMed ID: 25738589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum.
    Levijoki J; Pollesello P; Grossini E; Papp Z
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):827-832. PubMed ID: 35170487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which phosphodiesterase can decrease cardiac effects of 5-HT
    Neumann J; Käufler B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):991-1004. PubMed ID: 31016326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.